Chapel Hill, NC, United States of America

Sanjoy Mahanty

This inventor holds 7 USPTO granted patents. Top assignees: Paradigm Genetics, Inc., Icoria, Inc.. Active years: 2003-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sanjoy Mahanty. Retrieved from https://idiyas.com/inventor/sanjoy-mahanty

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 14.3

Average Co-Inventor Count = 14.0

ph-index = 2

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2003-2005

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations of Sanjoy Mahanty

Introduction

Sanjoy Mahanty is a notable inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibiotics targeting fungal pathogens. With a total of seven patents to his name, Mahanty's work has the potential to impact the treatment of fungal infections.

Latest Patents

Among his latest patents are methods for the identification of inhibitors of asparagine synthase as antibiotics. The present inventors have discovered that asparagine synthase is essential for fungal pathogenicity. Specifically, the inhibition of asparagine synthase gene expression in fungi results in no signs of successful infection or lesions. Thus, asparagine synthase can be used as a target for the identification of antibiotics, preferably antifungals. Accordingly, the present invention provides methods for the identification of compounds that inhibit asparagine synthase expression or activity. The methods of the invention are useful for the identification of antibiotics, preferably antifungals. Another significant patent involves methods for the identification of inhibitors of threonine synthase as antibiotics. The present inventors have discovered that threonine synthase is also essential for fungal pathogenicity. Specifically, the inhibition of threonine synthase gene expression in fungi results in no signs of successful infection or lesions. Thus, threonine synthase can be used as a target for the identification of antibiotics, preferably antifungals. Accordingly, the present invention provides methods for the identification of compounds that inhibit threonine synthase expression or activity. The methods of the invention are useful for the identification of antibiotics, preferably antifungals.

Career Highlights

Sanjoy Mahanty has worked with several prominent companies in the biotechnology sector, including Paradigm Genetics, Inc. and Icoria, Inc. His experience in these organizations has contributed to his expertise in the field and has facilitated his innovative research.

Collaborations

Some of his notable coworkers include Jeffrey R. Shuster and Matthew M. Tanzer. Their collaboration has likely enriched the research environment and fostered innovative ideas.

Conclusion

Sanjoy Mahanty is a distinguished inventor whose work in developing antifungal antibiotics has the potential to revolutionize treatment options. His contributions to biotechnology are significant and continue to influence the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…